Back to methods browser

First-pass extracted concept

single-cell and spatial transcriptomics

Candidate: toolkit itemType: assay method1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

single-cell transcriptomics, spatial transcriptomics

Extracted Explainers

What the tool is doing

Single-cell and spatial transcriptomics are presented as technologies for investigating the cellular and molecular basis of vascular diseases. The abstract states that they enable high-resolution mapping of cellular heterogeneity and functional alterations.

Source 1DOIPubMed

What problem it solves

They address the limited resolution and mechanistic insight of traditional diagnostic and clinical assays in vascular disease research.

Source 1DOIPubMed

Alternatives

The abstract contrasts these approaches with traditional imaging and clinical assays, and also discusses other emerging modalities such as photoacoustic imaging, organ-on-chip platforms, CRISPR/Cas9-based editing, and AI.

Source 1DOIPubMed

Evidence Snippets

Recent technological innovations, including single-cell and spatial transcriptomics ... have created new opportunities for investigating the cellular and molecular basis of VDs.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1capabilitysupports2025Source 1DOIPubMed

Single-cell and spatial transcriptomics, super-resolution and photoacoustic imaging, microfluidic organ-on-chip platforms, CRISPR/Cas9-based gene editing, and AI have created new opportunities for investigating the cellular and molecular basis of vascular diseases.

Claim 2capabilitysupports2025Source 1DOIPubMed

These emerging technologies enable high-resolution mapping of cellular heterogeneity and functional alterations, facilitating biomarker discovery, disease modeling, and therapeutic development in vascular diseases.

Claim 3future directionsupports2025Source 1DOIPubMed

Future progress in vascular disease research should prioritize multi-center large-scale validation studies, harmonization of assay protocols, and integration with clinical datasets and human samples.

Claim 4mechanistic insightsupports2025Source 1DOIPubMed

Integrating single-cell and multiomics approaches highlights disease-driving cell types and gene programs in vascular disease.